Making Sense of Biomarkers: Connecting Business Innovation and The Future of Medicine
If you don’t know what a biomarker is, this is your chance to learn what they are and why they matter to you. On this edition of Making Oregon, John Audette, founder of Amplion, a unique startup in Bend, will walk us through how their Biomarker Base is impacting Pharmaceutical and Research & Development companies. With the aid of Amplion’s database, companies are able to develop new drugs that get to market more quickly, with less cost, and fewer patient side-effects. John takes the time to make this technical, but critically important innovation understandable to all of us. We also get the story on why a serial founder who has already developed and sold two successful companies decided to begin all over again, enduring the rigors and stressors that come with any startup. We’ll also find out why Bend, Oregon is becoming such an attractive place for start-ups like Amplion, and how all of this may impact Oregon’s economic outlook.